Insight
Nature 446, 1038-1045 (26 April 2007) | doi:10.1038/nature05818; Published online 25 April 2007
Exploiting the defensive sugars of HIV-1 for drug and vaccine design
Christopher N. Scanlan1, John Offer2, Nicole Zitzmann1 & Raymond A. Dwek1
Abstract
The sustained effort towards developing an antibody vaccine against HIV/AIDS has provided much of our understanding of viral immunology. It is generally accepted that one of the main barriers to antibody neutralization of HIV is the array of protective structural carbohydrates that covers the antigens on the virus's surface. Intriguingly, however, recent findings suggest that these carbohydrates, which have evolved to protect HIV and promote its transmission, are also attractive therapeutic targets.
- Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.
- Scripps Oxford Laboratory, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.
Correspondence to: R.A.D. (Email: raymond.dwek@bioch.ox.ac.uk).
Author Information Reprints and permissions information is available at http://npg.nature.com/reprints/index.html
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Mass spectrometry provides sweet inspirationNature Biotechnology News and Views (01 Jun 2003)
EDEM an ER quality control receptorNature Structural Biology News and Views (01 May 2003)
The sweet side of biomarker discoveryNature Biotechnology News and Views (01 Sep 2006)
44OQ44Kk44Kq44Oe44O844Kr44O85o6i57Si44Gu55SY44GE6KmxNature Biotechnology News and Views (01 Sep 2006)
See all 5 matches for News And Views
